5vp0: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
m Protected "5vp0" [edit=sysop:move=sysop]
OCA (talk | contribs)
No edit summary
Line 3: Line 3:
The entry 5vp0 is ON HOLD  
The entry 5vp0 is ON HOLD  


Authors: Isaac Hoffman
Authors: Hoffman, I.D.


Description: Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders
Description: Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders
[[Category: Unreleased Structures]]
[[Category: Unreleased Structures]]
[[Category: Isaac Hoffman]]
[[Category: Hoffman, I.D]]

Revision as of 14:04, 17 May 2017

Unreleased structure

The entry 5vp0 is ON HOLD

Authors: Hoffman, I.D.

Description: Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders

Proteopedia Page Contributors and Editors (what is this?)

OCA